Fluvoxamine Improves Fatigue, QoL in Long COVID - Hematology Advisor

AI Briefing

• – Fluvoxamine, an antidepressant medication, has been found to improve fatigue and quality of life in patients with long COVID.
• – The study, published in the Journal of Clinical Psychopharmacology, suggests that fluvoxamine may be a potential treatment option for long COVID symptoms.
• – Researchers are urging healthcare providers to consider prescribing fluvoxamine to patients with long COVID who experience persistent fatigue and other quality-of-life issues.